Phase I Study of AR-42 and Decitabine in Acute Myeloid Leukemia
Phase of Trial: Phase I
Latest Information Update: 16 Mar 2018
At a glance
- Drugs AR 42 (Primary) ; Decitabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 12 Mar 2018 Status changed from active, no longer recruiting to completed.
- 06 Apr 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 01 Sep 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.